概括
在ATIC和ADA基因的遗传变异与中国风湿性关节炎患者的甲状腺素治疗反应有关. 这些发现可能有助于个性化RA治疗策略.
科学领域:
- 药物基因组学 药物基因组学
- 类风湿病学 类风湿病学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,影响关节.
- 甲甲酸 (MTX) 是一种常见的修饰疾病的抗风湿药物 (DMARD),用于治疗RA.
- 对MTX的个体反应各不相同,需要对预测生物标志物的研究.
研究的目的:
- 研究关键代谢基因中的遗传多态性和中国RA患者的MTX治疗结果之间的关联.
- 为了确定预测MTX治疗临床反应的遗传标记.
主要方法:
- 分析了115名接受MTX治疗的中国RA患者队列.
- 使用欧洲反风湿联盟 (EULAR) 标准和低疾病活性 (LDA) 28关节计数的疾病活动得分 (DAS28-ESR) 评估了临床反应.
- 在DHFR,TYMS,ATIC,ADA和AMPD1基因中进行了30个单核酸多态 (SNPs) 的基因定型.
主要成果:
- 在ATIC (rs2372536,rs4673991,rs4673993) 和ADA (rs2057638,rs6017375) 中的特定多态性与EULAR反应有关.
- 在一个衰退模型下,ADA rs371927多态性与EULAR响应相关.
- ADA多态 rs1799880和rs6031697与基于DAS28-ESR的LDA的实现有显著联系.
结论:
- 在中国的RA患者中,ATIC和ADA基因的遗传变异与MTX临床反应有显著的关联.
- 这些发现突显了药物遗传学方法在优化RA中MTX治疗的潜力.
- 需要在更大的队列中进一步验证以确认这些关联.
相关概念视频
Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
Phase II Reactions: Methylation Reactions
342
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
342
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271


